Class information for:
Level 2: FOOD AND DRUG LAW JOURNAL//CONFLICT OF INTEREST//ORPHAN DRUGS

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1464 7747 32.4 44%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
320 3       AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//MEDICATION ERRORS//AMERICAN JOURNAL OF HOSPITAL PHARMACY 39312
1464 2             FOOD AND DRUG LAW JOURNAL//CONFLICT OF INTEREST//ORPHAN DRUGS 7747
5442 1                   CONFLICT OF INTEREST//CONFLICTS OF INTEREST//DRUG INDUSTRY 1623
5560 1                   GENERIC SUBSTITUTION//GENERIC DRUGS//GENERIC MEDICINES 1606
16184 1                   ORPHAN DRUGS//RARE DISEASES//ORPHAN DRUG ACT 668
16303 1                   FOOD AND DRUG LAW JOURNAL//MEDICAL DEVICE INNOVATION//DEVICE APPROVAL 662
16866 1                   COMPULSORY LICENSING//ACCESS TO MEDICINES//DOHA DECLARATION 631
16867 1                   CLINICAL TRIAL RISK//DRUG DISCOVERY TODAY//TUFTS STUDY DRUG DEV 631
18020 1                   DIRECT TO CONSUMER ADVERTISING//DTCA//DIRECT TO CONSUMER ADVERTISING DTCA 570
21788 1                   CRHAM//SOCIOL SUBJECT GRP//CORPORATE BIAS 405
25741 1                   ANTIBACTERIAL DRUG DEVELOPMENT//INFECT GLOBAL MED DEV//ANTIBIOTIC INNOVATION 273
26445 1                   DRUG LAG//JAPANESE CLINICAL TRIALS//GLOBAL DRUG DEVELOPMENT 254
28025 1                   SURGICAL INNOVATION//ACCESS TO EXPERIMENTAL DRUGS//SYSTEMATIC REVIEW OF REASONS 215
28333 1                   FOOD AND DRUG LAW JOURNAL//INTELLECTUAL PROPERTY PROGRAM//ADDITIONAL PATENT 209

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 FOOD AND DRUG LAW JOURNAL journal 531532 5% 37% 366
2 CONFLICT OF INTEREST authKW 317633 3% 41% 197
3 ORPHAN DRUGS authKW 280461 2% 58% 122
4 GENERIC SUBSTITUTION authKW 262430 1% 87% 77
5 GENERIC DRUGS authKW 254639 2% 48% 136
6 PHARMACEUTICAL INDUSTRY authKW 199273 2% 28% 182
7 RARE DISEASES authKW 160716 2% 24% 169
8 DIRECT TO CONSUMER ADVERTISING authKW 157706 1% 65% 62
9 GENERIC MEDICINES authKW 147721 1% 83% 45
10 DRUG INDUSTRY authKW 114315 1% 48% 60

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Health Care Sciences & Services 31991 14% 1% 1090
2 Health Policy & Services 31342 11% 1% 826
3 Law 30785 12% 1% 930
4 Medical Ethics 19534 3% 2% 241
5 Pharmacology & Pharmacy 11645 24% 0% 1879
6 Ethics 10917 4% 1% 314
7 Social Sciences, Biomedical 6575 4% 1% 311
8 Medicine, General & Internal 5316 13% 0% 1042
9 Economics 2866 7% 0% 580
10 Social Issues 2478 2% 0% 148

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 TUFTS STUDY DRUG DEV 57096 0% 50% 29
2 EDMOND J SAFRA ETH 42441 0% 37% 29
3 OFF ORPHAN PROD DEV 38600 0% 70% 14
4 PROGRAM REGULAT THER EUT LAW PORTAL 32162 0% 58% 14
5 CRHAM 31517 0% 100% 8
6 STUDY DRUG DEV 28444 0% 43% 17
7 PHARMACOEPIDEMIOL PHARMACOECON 27860 1% 9% 79
8 P CRIBING GRP 20561 0% 33% 16
9 OFF PHARMACEUT IND 20259 0% 86% 6
10 SCI TECHNOL INNOVAT NEGLECTED DIS 20259 0% 86% 6

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 FOOD AND DRUG LAW JOURNAL 531532 5% 37% 366
2 DRUG INFORMATION JOURNAL 48952 2% 11% 117
3 THERAPEUTIC INNOVATION & REGULATORY SCIENCE 29257 1% 14% 52
4 DRUG DISCOVERY TODAY 29052 2% 6% 135
5 JOURNAL OF LAW MEDICINE & ETHICS 20101 1% 6% 86
6 AMERICAN JOURNAL OF LAW & MEDICINE 18821 1% 9% 53
7 PHARMACOECONOMICS 16695 1% 4% 97
8 EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH 16326 1% 9% 46
9 HEALTH POLICY 15778 1% 4% 113
10 BIOTECHNOLOGY LAW REPORT 13023 0% 15% 22

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CONFLICT OF INTEREST 317633 3% 41% 197 Search CONFLICT+OF+INTEREST Search CONFLICT+OF+INTEREST
2 ORPHAN DRUGS 280461 2% 58% 122 Search ORPHAN+DRUGS Search ORPHAN+DRUGS
3 GENERIC SUBSTITUTION 262430 1% 87% 77 Search GENERIC+SUBSTITUTION Search GENERIC+SUBSTITUTION
4 GENERIC DRUGS 254639 2% 48% 136 Search GENERIC+DRUGS Search GENERIC+DRUGS
5 PHARMACEUTICAL INDUSTRY 199273 2% 28% 182 Search PHARMACEUTICAL+INDUSTRY Search PHARMACEUTICAL+INDUSTRY
6 RARE DISEASES 160716 2% 24% 169 Search RARE+DISEASES Search RARE+DISEASES
7 DIRECT TO CONSUMER ADVERTISING 157706 1% 65% 62 Search DIRECT+TO+CONSUMER+ADVERTISING Search DIRECT+TO+CONSUMER+ADVERTISING
8 GENERIC MEDICINES 147721 1% 83% 45 Search GENERIC+MEDICINES Search GENERIC+MEDICINES
9 DRUG INDUSTRY 114315 1% 48% 60 Search DRUG+INDUSTRY Search DRUG+INDUSTRY
10 REFERENCE PRICING 99620 0% 82% 31 Search REFERENCE+PRICING Search REFERENCE+PRICING

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 DYLST, P , VULTO, A , SIMOENS, S , (2013) DEMAND-SIDE POLICIES TO ENCOURAGE THE USE OF GENERIC MEDICINES: AN OVERVIEW.EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. VOL. 13. ISSUE 1. P. 59 -72 70 88% 19
2 REID, EE , ALIKHAN, A , BRODELL, RT , (2012) DRUG SAMPLING IN DERMATOLOGY.CLINICS IN DERMATOLOGY. VOL. 30. ISSUE 2. P. 192-201 73 86% 2
3 DUNNE, SS , DUNNE, CP , (2015) WHAT DO PEOPLE REALLY THINK OF GENERIC MEDICINES? A SYSTEMATIC REVIEW AND CRITICAL APPRAISAL OF LITERATURE ON STAKEHOLDER PERCEPTIONS OF GENERIC DRUGS.BMC MEDICINE. VOL. 13. ISSUE . P. - 58 89% 3
4 DUNNE, SS , (2016) WHAT DO USERS OF GENERIC MEDICINES THINK OF THEM? A SYSTEMATIC REVIEW OF CONSUMERS' AND PATIENTS' PERCEPTIONS OF, AND EXPERIENCES WITH, GENERIC MEDICINES.PATIENT-PATIENT CENTERED OUTCOMES RESEARCH. VOL. 9. ISSUE 6. P. 499 -510 46 94% 0
5 FADARE, JO , ADEOTI, AO , DESALU, OO , ENWERE, OO , MAKUSIDI, AM , OGUNLEYE, O , SUNMONU, TA , TRUTER, I , AKUNNE, OO , GODMAN, B , (2016) THE PRESCRIBING OF GENERIC MEDICINES IN NIGERIA: KNOWLEDGE, PERCEPTIONS AND ATTITUDES OF PHYSICIANS.EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH. VOL. 16. ISSUE 5. P. 639 -650 49 79% 1
6 WAZANA, A , (2000) PHYSICIANS AND THE PHARMACEUTICAL INDUSTRY - IS A GIFT EVER JUST A GIFT?.JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. VOL. 283. ISSUE 3. P. 373 -380 37 95% 693
7 ZELEI, T , MOLNAR, MJ , SZEGEDI, M , KALO, Z , (2016) SYSTEMATIC REVIEW ON THE EVALUATION CRITERIA OF ORPHAN MEDICINES IN CENTRAL AND EASTERN EUROPEAN COUNTRIES.ORPHANET JOURNAL OF RARE DISEASES. VOL. 11. ISSUE . P. - 46 87% 0
8 FADLALLAH, R , NAS, H , NAAMANI, D , EL-JARDALI, F , HAMMOURA, I , AL-KHALED, L , BRAX, H , KAHALE, L , AKL, EA , (2016) KNOWLEDGE, BELIEFS AND ATTITUDES OF PATIENTS AND THE GENERAL PUBLIC TOWARDS THE INTERACTIONS OF PHYSICIANS WITH THE PHARMACEUTICAL AND THE DEVICE INDUSTRY: A SYSTEMATIC REVIEW.PLOS ONE. VOL. 11. ISSUE 8. P. - 41 95% 0
9 DESMARAIS, JE , BEAUCLAIR, L , MARGOLESE, HC , (2011) SWITCHING FROM BRAND-NAME TO GENERIC PSYCHOTROPIC MEDICATIONS: A LITERATURE REVIEW.CNS NEUROSCIENCE & THERAPEUTICS. VOL. 17. ISSUE 6. P. 750-760 46 82% 24
10 RAAD, R , APPELBAUM, PS , (2012) RELATIONSHIPS BETWEEN MEDICINE AND INDUSTRY: APPROACHES TO THE PROBLEM OF CONFLICTS OF INTEREST.ANNUAL REVIEW OF MEDICINE, VOL 63. VOL. 63. ISSUE . P. 465-477 39 95% 4

Classes with closest relation at Level 2


Rank Class id link
1 1726 HEALTH TECHNOLOGY ASSESSMENT//INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE//PRIORITY SETTING
2 2978 PHARMACOVIGILANCE//ADVERSE DRUG REACTIONS//DRUG SAFETY
3 1670 ANTIMICROBIAL STEWARDSHIP//ANTIBIOTIC USE//ANTIBIOTIC STEWARDSHIP
4 3609 COUNTERFEIT MEDICINES//ONLINE PHARMACIES//SILDENAFIL ANALOGUE
5 1009 EVIDENCE BASED MEDICINE//PUBLICATION BIAS//RESEARCH SYNTHESIS METHODS
6 3420 CONTINUAL REASSESSMENT METHOD//DOSE FINDING//PHASE I TRIAL
7 2852 PLAGIARISM//SCIENCE AND ENGINEERING ETHICS//ACADEMIC DISHONESTY
8 3777 FOOD AND DRUG LAW JOURNAL//BROMATOL 2//REQUIMTE SCI CHEM
9 2630 NEW ZEALAND MEDICAL JOURNAL//FUNDHOLDING//HOSPITAL GOVERNANCE
10 2277 JOURNAL OF THE COPYRIGHT SOCIETY OF THE USA//LAW//IIC-INTERNATIONAL REVIEW OF INDUSTRIAL PROPERTY AND COPYRIGHT LAW

Go to start page